Eurofins Scientific SE (ERFSF)$73.00
Market Cap: 11.48 BCurrency: USD
Research Snapshot
Static fundamentals, valuation context, and investor signals for Eurofins Scientific SE (ERFSF).
HEALTHCARE
DIAGNOSTICS & RESEARCH
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
N/A
ROIC, N/A FCF margin
Growth
N/A
5Y sales (revenue) CAGR
Balance sheet
N/A
Debt/equity, N/A current ratio
Superinvestors
2
Top: Thomas Russo (2.6%)
Strengths to research
No strong positive screening signals were detected from the checked-in dataset.
Watchouts
- Full metrics are not available yet for this ticker.
Annual data: 0 periods
Quarterly data: 3 periods
Stock snapshot: May 24, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for ERFSF.
Grade F
0
/ 100
Peer Comparison
Target stock against 8 market-cap comparable peers.
Heat map: red worst to green best
| ERFSF Target | Eurofins Scientific SE | $11.5B | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| ICLR | ICON plc | $11.4B | 12.3x | 9.7x | 8.3% | 24.2% | 13.5% | N/A | -0.3x | N/A |
| ILMN | Illumina Inc. | $12.4B | 26.5x | 11.8x | 31.2% | 6.0% | 21.4% | 66.1% | -1.3x | N/A |
| MEDP | Medpace Holdings Inc. | $8.6B | 28.3x | 11.9x | 98.3% | 22.3% | 26.9% | N/A | -0.9x | N/A |
| DGX | Quest Diagnostics | $19.8B | 22.3x | 18.5x | 7.7% | 3.2% | 12.3% | N/A | 2.5x | N/A |
| LH | Labcorp Holdings Inc. | $20.7B | 24.8x | 16.7x | 10.2% | -0.0% | 8.6% | 28.8% | -0.3x | N/A |
| NTRA | Natera Inc. | $21.4B | -133.7x | 186.2x | -12.2% | 42.6% | 4.7% | N/A | N/A | N/A |
| CRL | Charles River Labs | $5.9B | -55.1x | 10.9x | -4.6% | 6.5% | 12.9% | N/A | -0.5x | N/A |
| MTD | Mettler-Toledo International Inc. | $22.7B | 26.2x | 29.2x | 42.1% | 5.5% | 21.1% | 59.4% | N/A | N/A |
Financial Charts
No financial data available for ERFSF (annual).
2 superinvestors own ERFSF
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Thomas Russo Gardner Russo & Quinn | 3,096,404 | $224M | 2.63% | 0.0% |
| Steven Romick FPA Crescent Fund | 1,637,209 | $87M | 1.53% | 0.0% |